[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Oncology Biosimilars Market Report 2018

February 2018 | 103 pages | ID: A59121A5C7CEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Oncology Biosimilars market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Oncology Biosimilars for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Oncology Biosimilars market competition by top manufacturers/players, with Oncology Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Celltrion Inc.
  • Pfizer Inc.
  • Biocon
  • BIOCAD
  • Apotex Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Sandoz International GmbH
  • Intas Pharmaceuticals Ltd.
  • STADA Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd.
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • G-CSF
  • Hematopoietic Agents
  • Monoclonal Antibodies
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Oncology Biosimilars Market Report 2018

1 ONCOLOGY BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars by Product Category
  1.2.1 Asia-Pacific Oncology Biosimilars Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Oncology Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 G-CSF
  1.2.4 Hematopoietic Agents
  1.2.5 Monoclonal Antibodies
1.3 Asia-Pacific Oncology Biosimilars Market by Application/End Users
  1.3.1 Asia-Pacific Oncology Biosimilars Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 Asia-Pacific Oncology Biosimilars Market by Region
  1.4.1 Asia-Pacific Oncology Biosimilars Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Oncology Biosimilars (2013-2025)
  1.5.1 Asia-Pacific Oncology Biosimilars Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Oncology Biosimilars Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC ONCOLOGY BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Oncology Biosimilars Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Oncology Biosimilars Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Oncology Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Oncology Biosimilars (Volume and Value) by Type
  2.2.1 Asia-Pacific Oncology Biosimilars Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Oncology Biosimilars Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Oncology Biosimilars (Volume) by Application
2.4 Asia-Pacific Oncology Biosimilars (Volume and Value) by Region
  2.4.1 Asia-Pacific Oncology Biosimilars Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Oncology Biosimilars Revenue and Market Share by Region (2013-2018)

3 CHINA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 China Oncology Biosimilars Sales and Value (2013-2018)
  3.1.1 China Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  3.1.3 China Oncology Biosimilars Sales Price Trend (2013-2018)
3.2 China Oncology Biosimilars Sales Volume and Market Share by Type
3.3 China Oncology Biosimilars Sales Volume and Market Share by Application

4 JAPAN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Oncology Biosimilars Sales and Value (2013-2018)
  4.1.1 Japan Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Oncology Biosimilars Sales Price Trend (2013-2018)
4.2 Japan Oncology Biosimilars Sales Volume and Market Share by Type
4.3 Japan Oncology Biosimilars Sales Volume and Market Share by Application

5 SOUTH KOREA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Oncology Biosimilars Sales and Value (2013-2018)
  5.1.1 South Korea Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Oncology Biosimilars Sales Price Trend (2013-2018)
5.2 South Korea Oncology Biosimilars Sales Volume and Market Share by Type
5.3 South Korea Oncology Biosimilars Sales Volume and Market Share by Application

6 TAIWAN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Oncology Biosimilars Sales and Value (2013-2018)
  6.1.1 Taiwan Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Oncology Biosimilars Sales Price Trend (2013-2018)
6.2 Taiwan Oncology Biosimilars Sales Volume and Market Share by Type
6.3 Taiwan Oncology Biosimilars Sales Volume and Market Share by Application

7 INDIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India Oncology Biosimilars Sales and Value (2013-2018)
  7.1.1 India Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  7.1.3 India Oncology Biosimilars Sales Price Trend (2013-2018)
7.2 India Oncology Biosimilars Sales Volume and Market Share by Type
7.3 India Oncology Biosimilars Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Oncology Biosimilars Sales and Value (2013-2018)
  8.1.1 Southeast Asia Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Oncology Biosimilars Sales Price Trend (2013-2018)
8.2 Southeast Asia Oncology Biosimilars Sales Volume and Market Share by Type
8.3 Southeast Asia Oncology Biosimilars Sales Volume and Market Share by Application

9 AUSTRALIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Oncology Biosimilars Sales and Value (2013-2018)
  9.1.1 Australia Oncology Biosimilars Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Oncology Biosimilars Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Oncology Biosimilars Sales Price Trend (2013-2018)
9.2 Australia Oncology Biosimilars Sales Volume and Market Share by Type
9.3 Australia Oncology Biosimilars Sales Volume and Market Share by Application

10 ASIA-PACIFIC ONCOLOGY BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Celltrion Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Oncology Biosimilars Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Celltrion Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Pfizer Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Oncology Biosimilars Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Pfizer Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Biocon
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Oncology Biosimilars Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 BIOCAD
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Oncology Biosimilars Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 BIOCAD Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Apotex Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Oncology Biosimilars Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Apotex Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Dr. Reddy’s Laboratories Ltd.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Oncology Biosimilars Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Sandoz International GmbH
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Oncology Biosimilars Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Sandoz International GmbH Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Intas Pharmaceuticals Ltd.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Oncology Biosimilars Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 STADA Arzneimittel AG
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Oncology Biosimilars Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Teva Pharmaceutical Industries Ltd.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Oncology Biosimilars Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview

11 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Oncology Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oncology Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ONCOLOGY BIOSIMILARS MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Oncology Biosimilars Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Oncology Biosimilars Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Oncology Biosimilars Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Oncology Biosimilars Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Oncology Biosimilars Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Oncology Biosimilars Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Oncology Biosimilars Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Oncology Biosimilars Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Oncology Biosimilars Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Oncology Biosimilars Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Oncology Biosimilars Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Oncology Biosimilars Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology Biosimilars
Figure Asia-Pacific Oncology Biosimilars Sales Volume (MT) by Type (2013-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
Figure G-CSF Product Picture
Figure Hematopoietic Agents Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Asia-Pacific Oncology Biosimilars Sales (MT) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Oncology Biosimilars by Application in 2017
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Asia-Pacific Oncology Biosimilars Market Size (Million USD) by Region (2013-2025)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Volume (MT) and Growth Rate (2013-2025)
Figure Asia-Pacific Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Oncology Biosimilars Market Major Players Product Sales Volume (MT)(2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales (MT) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Oncology Biosimilars Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Oncology Biosimilars Sales Share by Players/Suppliers
Figure Asia-Pacific Oncology Biosimilars Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Oncology Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Oncology Biosimilars Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Oncology Biosimilars Revenue Share by Players
Figure 2017 Asia-Pacific Oncology Biosimilars Revenue Share by Players
Table Asia-Pacific Oncology Biosimilars Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales Share by Type (2013-2018)
Figure Sales Market Share of Oncology Biosimilars by Type (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Oncology Biosimilars Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oncology Biosimilars by Type (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales Volume (MT) and Market Share by Region (2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales Share by Region (2013-2018)
Figure Sales Market Share of Oncology Biosimilars by Region (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Region in 2017
Table Asia-Pacific Oncology Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Oncology Biosimilars Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Oncology Biosimilars by Region (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Revenue Market Share by Region in 2017
Table Asia-Pacific Oncology Biosimilars Sales Volume (MT) and Market Share by Application (2013-2018)
Table Asia-Pacific Oncology Biosimilars Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Oncology Biosimilars Sales Market Share by Application (2013-2018)
Figure China Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table China Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table China Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure China Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table China Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table China Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure China Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure Japan Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table Japan Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table Japan Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Japan Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table Japan Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table Japan Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Japan Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure South Korea Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure South Korea Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table South Korea Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table South Korea Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure South Korea Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table South Korea Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table South Korea Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure South Korea Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure Taiwan Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Taiwan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table Taiwan Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table Taiwan Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table Taiwan Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table Taiwan Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure India Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table India Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table India Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure India Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table India Oncology Biosimilars Sales Volume (MT) by Application (2013-2018)
Table India Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure India Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure Southeast Asia Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table Southeast Asia Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table Southeast Asia Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table Southeast Asia Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table Southeast Asia Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Oncology Biosimilars Sales Volume Market Share by Application in 2017
Figure Australia Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Australia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Oncology Biosimilars Sales Price (USD/Kg) Trend (2013-2018)
Table Australia Oncology Biosimilars Sales Volume (MT) by Type (2013-2018)
Table Australia Oncology Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Australia Oncology Biosimilars Sales Volume Market Share by Type in 2017
Table Australia Oncology Biosimilars Sales Volume (MT) by Applications (2013-2018)
Table Australia Oncology Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Australia Oncology Biosimilars Sales Volume Market Share by Application in 2017
Table Celltrion Inc. Oncology Biosimilars Basic Information List
Table Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Celltrion Inc. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Pfizer Inc. Oncology Biosimilars Basic Information List
Table Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Pfizer Inc. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Biocon Oncology Biosimilars Basic Information List
Table Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Biocon Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Biocon Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Biocon Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table BIOCAD Oncology Biosimilars Basic Information List
Table BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure BIOCAD Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure BIOCAD Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure BIOCAD Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Apotex Inc. Oncology Biosimilars Basic Information List
Table Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Apotex Inc. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Apotex Inc. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Apotex Inc. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Basic Information List
Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Sandoz International GmbH Oncology Biosimilars Basic Information List
Table Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Sandoz International GmbH Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Basic Information List
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table STADA Arzneimittel AG Oncology Biosimilars Basic Information List
Table STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Basic Information List
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT) and Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Market Share in Asia-Pacific (2013-2018)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue Market Share in Asia-Pacific (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2017
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Asia-Pacific Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Price (USD/Kg) and Trend Forecast (2018-2025)
Table Asia-Pacific Oncology Biosimilars Sales Volume (MT) Forecast by Region (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Oncology Biosimilars Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Revenue Market Share Forecast by Region in 2025
Figure China Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure South Korea Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Taiwan Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Oncology Biosimilars Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Australia Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Oncology Biosimilars Sales (MT) Forecast by Type (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Oncology Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Oncology Biosimilars Price (USD/Kg) Forecast by Type (2018-2025)
Table Asia-Pacific Oncology Biosimilars Sales (MT) Forecast by Application (2018-2025)
Figure Asia-Pacific Oncology Biosimilars Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories